H Lundbeck A/S

H Lundbeck A/S EBIT per Employee

The EBIT per Employee of H Lundbeck A/S (LUN.CO) as of Nov 6, 2026 is 1.13 M DKK. In the previous year, EBIT per Employee was 581,023.45 DKK — a change of 93.98% (higher).

EBIT per Employee

1.13 MDKK

YoY

93.98%

Last updated:

EBIT per Employee of H Lundbeck A/S is 2025 1.13 M DKK. EBIT per Employee of H Lundbeck A/S was 2024 581,023.45 DKK. It decreases by 93.98% higher compared to the previous year.

The H Lundbeck A/S EBIT per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Employee
Date
EBIT per Employee
Jan 1, 2018
941,897.65 DKK
Jan 1, 2019
641,080.31 DKK
Jan 1, 2020
353,589.20 DKK
Jan 1, 2021
357,142.86 DKK
Jan 1, 2022
506,751.95 DKK
Jan 1, 2023
567,697.23 DKK
Jan 1, 2024
581,023.45 DKK
Jan 1, 2025
1.13 M DKK
The H Lundbeck A/S EBIT per Employee history
YEAREBIT per EmployeeYoY
1.13 MDKK+93.98%
581,023.45DKK+2.35%
567,697.23DKK+12.03%
506,751.95DKK+41.89%
357,142.86DKK+1.01%
353,589.20DKK-44.84%
641,080.31DKK-31.94%
941,897.65DKK+20.26%
783,226.72DKK+92.32%
407,249.47DKK-135.11%
-1.16 MDKK-6,693.94%
17,590.62DKK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

H Lundbeck A/S Stock analysis

What does H Lundbeck A/S do? H Lundbeck A/S is a Danish company that was founded in 1915 by Hans Lundbeck. Since its inception, the company has focused on researching and developing medications that improve the lives of people with neuropsychiatric disorders. Lundbeck's business model is based on a clear strategy and a strong focus on the research and development of pharmaceuticals. The company has four main therapy areas: depression, anxiety disorders, Alzheimer's, and Parkinson's. Lundbeck products are sold in over 100 countries worldwide and are known for their effectiveness and high quality. Over the years, Lundbeck has also focused on developing innovative treatment methods, including research on new drugs and therapies based on neurotransmitters such as serotonin, dopamine, and norepinephrine. With the acquisition of Alder BioPharmaceuticals in 2019, Lundbeck also expanded its portfolio in the field of migraine therapy. Some of Lundbeck's most well-known products include Lexapro, Cipralex, Selincro, Abilify Maintena, and Brintellix. These medications are used in the treatment of depression, anxiety disorders, alcoholism, bipolar disorders, and migraines. In addition to selling medications, Lundbeck also provides training and support for healthcare professionals and patients. Lundbeck is also distinguished by its commitment to social engagement and works closely with nonprofit organizations to raise awareness of neuropsychiatric disorders. The company has also launched various programs to improve access to medical care in particularly affected regions. In 2020, Lundbeck exceeded 18,000 employees worldwide and had a revenue of 16.6 billion Danish kroner. Lundbeck is listed on NASDAQ OMX Copenhagen and is controlled by the Lundbeck Foundation, which holds over 70% of the company's ownership. In summary, Lundbeck is a leading company in the field of neuropsychiatric medicine and is dedicated to improving the lives of people with these serious disorders. The company has made a name for itself through its successful research and development of therapies and medications, as well as its strong focus on social engagement and corporate social responsibility. H Lundbeck A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about H Lundbeck A/S stock

EBIT per Employee of H Lundbeck A/S is 1.13 M DKK in 2025.

EBIT per Employee of H Lundbeck A/S changed from 581,023.45 DKK to 1.13 M DKK, representing a 93.98% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Employee H Lundbeck A/S since 2006 – with annual values, charts, and detailed analysis.

EBIT per employee measures operating profit per employee, showing how efficiently the workforce generates operating earnings.

EBIT per Employee's DKK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT per Employee's H Lundbeck A/S historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — H Lundbeck A/S

All Key Metrics — H Lundbeck A/S